Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 19 of 5804
-
Engineered immune cells take on pancreatic cancer in first human trial
Disease control Not yet recruitingPancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, with limited therapeutic options and a five-year survival rate below 10 % in advanced stages. Standard treatments, such as multi-agent chemotherapy, provide only marginal survival benefits and are often as…
Phase: PHASE1, PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 26, 2026 12:34 UTC
-
Could brain pacemakers slow Alzheimer's? new trial tests DBS
Disease control ENROLLING_BY_INVITATIONThis project will investigate the potential of Deep Brain Stimulation to improve cognitive abilities and counteract the effects of Alzheimer's disease. Deep Brain Stimulation electrodes targeting the Nucleus Basalis of Meynert (NB) will be implanted bilaterally in a cohort of pat…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New malaria combo aims to stop relapses for good
⭐️ CURE ⭐️ Not yet recruitingThe goal of this Phase 2b study is to examine the safety and efficacy of the combination of SJ733, an investigational agent, and tafenoquine for the radical cure of uncomplicated P. vivax malaria monoinfection in adult participants and determine the contributions of SJ733 to the …
Phase: PHASE2 • Sponsor: R. Kiplin Guy • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 12:38 UTC
-
Could umbilical cord stem cells help ARDS patients breathe again?
Disease control Not yet recruitingThis study evaluates the safety and potential therapeutic activity of JadiCell™, an investigational umbilical cord-derived mesenchymal stem cell therapy, in patients diagnosed with Acute Respiratory Distress Syndrome (ARDS). JadiCells are administered intravenously and are intend…
Phase: PHASE3 • Sponsor: Breathe Biologics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for Platinum-Resistant ovarian cancer: BL-M07D1 enters phase 3 trial
Disease control Not yet recruitingThis trial is a registrational Phase III, randomized, open-label, multicenter study to evaluate the efficacy and safety of BL-M07D1 in patients with HER2-expressing platinum-resistant recurrent epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer.
Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Teens create videos to stop gun violence before it starts
Prevention ENROLLING_BY_INVITATIONGun violence is the number one reason children die in the U.S. In big cities, most of these cases come from shootings related to assaults and homicides. There aren't many effective ways right now to prevent kids from either becoming victims or getting involved in gun violence the…
Phase: NA • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Prevention
Last updated Jun 27, 2026 12:26 UTC
-
Womb transplant trial offers hope for women with uterine infertility
Disease control Recruiting nowOur study will explore the feasibility of initiating a deceased donor uterine transplant program in addition to the existing living donor IRB at BWH. Using the template established by teams around the world, we will identify emotionally and socially stable females of reproductiv…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Womb transplant trial offers hope for women born without a uterus
Disease control Recruiting nowThis study will examine the feasibility of initiating a uterine transplant program for Absolute Uterine Factor Infertility (AUFI) at Brigham and Women's Hospital. The investigators plan to screen 30 patients with a goal of enrolling 10 patients. (5 donors and 5 recipients) After …
Phase: PHASE2, PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
HIV cocktail aims to free patients from daily pills
Disease control Not yet recruitingA modern and urgent challenge in fighting HIV infection is to achieve sustained HIV remission without the use of antiretrovirals. The investigators' preliminary data indicate that the use of combined strategies to mitigate the HIV proviral reservoir size among individuals with su…
Phase: PHASE2 • Sponsor: Federal University of São Paulo • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New triple therapy aims to reverse early diabetes
Disease control Not yet recruitingThe goal of this clinical trial is to learn the efficacy of combination therapy with tirzepatide, empagliflozin and pioglitazone versus standard therapy in newly diagnosed type 2 diabetes. The main objectives to achieve are: 1. To compare efficacy of the triple combination thera…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New pill targets stubborn colorectal cancer mutation
Disease control Recruiting nowThis study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab or panitumumab and cetuximab plus mFOLFOX in patients with metastatic KRAS G12D - mutated Colorectal Cancer
Phase: PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Engineered immune cells take aim at childhood autoimmune diseases
Disease control Not yet recruitingThis is a single-arm, open-label, phase I clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of RD06-05, a universal CD19/BCMA dual-targeting chimeric antigen receptor T-cell (CAR-T), in pediatric and adolescent patients with ref…
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug aims to outperform current therapy in Hard-to-Treat breast cancer
Disease control Not yet recruitingThis trial is a randomized, open-label, multicenter Phase II study designed to evaluate the efficacy and safety of BL-M07D1 in patients with unresectable locally recurrent or metastatic HR-positive, HER2-low expressing breast cancer.
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Triple-Drug attack aims to stop liver cancer recurrence after surgery
Disease control Not yet recruitingThis study is conducted to evaluate the efficacy and safety of SHR-8068 combined with Adebrelimab and Apatinib compared with Adebrelimab combined with Apatinib in perioperative treatment of resectable hepatocellular carcinoma with intermediate or high recurrence risk.
Phase: PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Lab-Grown tumor clusters guide tailored bladder cancer therapy
Disease control Not yet recruitingThis study evaluates Patient-derived Tumor-like Cell Clusters (PTC)-guided individualized neoadjuvant therapy in patients with muscle-invasive bladder cancer who are candidates for radical cystectomy.
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Triple-Drug cocktail plus targeted procedure aims to tame incurable liver cancer
Disease control Not yet recruitingThis is a multicenter, Phase 3 clinical trial to evaluate the efficacy and safety of SHR-8068, Adebrelimab, and Bevacizumab and TACE versus Placebo with TACE in incurable hepatocellular carcinoma. Participants will continue treatment until disease progresses, intolerable toxicit…
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Particle beam and immune therapy join forces against cervical cancer
Disease control Recruiting nowThis study explores the therapeutic effect of carbon ion radiotherapy plus immunotherapy and chemotherapy for locally advanced cervical cancer.
Phase: NA • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a shot replace daily HIV pills? new trial tests injectable combo
Disease control Not yet recruitingThe study will have two portions: Phase 2 and Phase 3. Phase 2 will further have 2 parts: Part A and Part B. The goal of Phase 2, Part A is to assess the effectiveness of study drugs GS-3242 plus Lenacapavir (LEN) versus Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide …
Phase: PHASE2, PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Experimental drug aims to tackle both obesity and knee arthritis
Disease control Not yet recruitingThe study is being conducted to evaluate the efficacy and safety of Ribupatide Injection in participants with obesity and knee osteoarthritis, and to explore its improvement on knee joint structure.
Phase: PHASE3 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a Three-Drug cocktail replace chemo for follicular lymphoma?
Disease control Not yet recruitingThis study intends to conduct a prospective, multicenter, open-label, randomized controlled clinical trial to systematically evaluate the efficacy and safety of the orelabrutinib plus obinutuzumab and lenalidomide (RO2) regimen versus the obinutuzumab-combined chemotherapy (O-che…
Phase: PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC